Willis Lease Finance executive chairman Willis sells $2.5m stock

Willis Lease Finance (WLFC) saw a Q2 revenue beat at $194M vs $178M expectations, but EPS missed sharply at $1.31 vs $3.26, reflecting cost/financing headwinds. The company also agreed to acquire three commercial buildings in Florida for $118M, while Freedom Broker upgraded the stock to “Buy” but cut the price target to $71.0 from $75.33. Separately, Executive Chairman Charles Willis sold about $2.54M of shares (46,500 shares) under a 10b5-1 plan as the stock trades near $55.15, following a roughly 19% 6-month decline.

Analysis

WLFC reads more like a funding-spread and asset-mix story than a simple operating beat. When revenue is helped by asset sales and fees, the market should focus on whether lease earnings can cover a higher cost of capital; if financing charges keep rising, reported growth can mask eroding equity value. The 10b5-1 sales are not a clean signal by themselves, but they matter because they arrive when the stock is still trying to re-rate on the idea that headline growth is durable.

Relative winners are larger aircraft lessors with cheaper funding and deeper collateral pools, where residual-value and refinancing risk are better absorbed. Smaller niche operators like WLFC can look optically cheap until the market re-prices book value quality and the durability of after-market margins; that is especially true if management keeps leaning into lower-turn asset sales or property-heavy expansion that ties up capital. Over the next 1-3 months, the key catalyst is whether the next print shows operating income keeping pace with revenue; over 6-12 months, it is whether leverage and interest expense stabilize enough to justify the current multiple.

Contrarian view: the selloff may already be discounting a lot of the bad mix, and if engine sales normalize the stock can bounce sharply. The bearish thesis breaks if financing costs flatten and EPS starts converging toward revenue growth; absent that, this is not an obvious standalone long. TGT has no direct fundamental read-through here beyond generic market beta, so I would not force a trade on it.

Key Decisions for Investors

• WLFC: do not add on headline strength; treat rallies into the high-$50s as an opportunity to reduce exposure until the next quarter proves earnings conversion is improving. Risk/reward is poor if financing costs keep outpacing asset-yield growth.
• Relative value: long AER / short WLFC for 1-3 months. AER should be less sensitive to funding volatility and residual-value noise; the pair works if the market starts rewarding balance-sheet quality over revenue optics.
• If you want a tactical bearish expression, use a small WLFC put spread into the next earnings window rather than outright short. This caps premium risk and targets a re-rating if EPS again lags revenue.
• Set a watch item on WLFC interest expense and debt maturity disclosures: if funding costs stop rising and operating margins inflect, cover any bearish exposure immediately. That would be the clearest falsifier.
• No trade in TGT on this item; any move there is likely unrelated beta and not a company-specific catalyst.